|Title||Assoc Director Catalyst|
|School||UCSF School of Medicine|
|Address||550 16th. Street|
San Francisco CA 94158
|Title||Director, CTSI T1 Translational Research|
|University College London||PhD||1986||Medicine|
|Royal Society of Chemistry (London)||2012||Fellowship |
Cathy has over 25 years experience of drug discovery in Industry and academia. She was Associate Director of Pharmacology for the Respiratory Inflammation CEDD GlaxoSmithKline, responsible for Respiratory and Inflammation lead optimization activities. She is a Pharmacologist with a wide experience of a number of therapeutic areas (i.e. Oncology, Inflammatory diseases, Respiratory, Cardiovascular, Rheumatology, Gastroenterology, Infection), including leading interdisciplinary projects from Target identification through to Clinical Proof of Concept and to Phase III/IV clinical studies. She has been involved in leading project teams, which identified of over 20 development compound candidates and >10 marketed small molecule and biological drugs.
Cathy led the development of innovative academic-industry drug discovery models in the UK and has recently published a review of UK academic drug discovery (Nature Reviews Drug Discovery 13, Jan 2014). She founded, managed and developed a successful and innovative interdisciplinary research drug discovery centre (DDC) at Imperial College London. Cathy is a founder of a number of spinout companies progressing DDC projects towards the clinic.
Since moving to California in February 2013, Cathy has been an advisor to UCSF CTSI and Stanford SPARK programmes, is Director of Ginkgo Consulting, and has recently joined the CTSI Early Translational Research therapeutics track.
Derived automatically from this person's publications.
People who share related concepts with this person.